Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
Unit, UMR 8199/ U1283 CNRS, INSERM, Institut Pasteur de Lille, CHU Lille, Université Lille) in the “Metabolome, Microbiome and Metabolic Diseases” team and the metabolomic platform IMPACT-PM, directed by
-
. LipidBRIGHT builds on available patient cohorts, advanced technologies and established cooperations and strives to synergistically improve structural training on European level. LipidBRIGHT will nurture the
-
heroin self-administration. Analyze synaptic mechanisms using western blot, RT-qPCR, immunohistochemistry, and electrophysiology (in collaboration). Characterize structural adaptations (dendrites, spines
-
10 Mar 2026 Job Information Organisation/Company INSERM 1116 Research Field Medical sciences » Health sciences Biological sciences » Biology Pharmacological sciences » Clinical pharmacology
-
cohorts, advanced technologies and established cooperations and strives to synergistically improve structural training on European level. LipidBRIGHT will nurture the development of young, broadly-trained
-
24 Jan 2026 Job Information Organisation/Company Paris Cardiovascular Research Center, Inserm U970 Research Field Biological sciences » Biology Psychological sciences » Psychology Medical sciences
-
a Research Infrastructure? No Offer Description Structure & Research environment The candidate will join the TREX laboratory (Translational Research and Experimental Corneal Surgery) at the Hôpital
-
existing structural and functional MRI data, acquire new data in collaboration with clinical researchers, and prepare publications and conference presentations. - Study preparation - Data acquisition (MRI
-
10 Jan 2026 Job Information Organisation/Company BENAJIBA team - INSERM U1342 - Saint-Louis Research Institute Research Field Biological sciences Researcher Profile Established Researcher (R3
-
allow researchers to explore alternative approaches. Target trial emulation is a structured framework to design observational studies that mimic randomized controlled trials, while reducing methodological